Foresee Pharmaceuticals Co., Ltd.

Industry

  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Biotechnology
    • Drug Discovery Technologies
      • ADMET

Other Names/Subsidiaries

  • Foresee Pharmaceuticals Inc.
See more in Biomedtracker

Latest on Foresee Pharmaceuticals Co., Ltd.

Pink Sheet

Janssen’s BCMA-Targeting CAR-T, AstraZeneca’s Evusheld Among EU Verdict Hopefuls

 
• By Vibha Sharma

Sponsors of six new drugs are set to learn this week whether their products are on track for possible EU-wide approval, including Janssen for its CAR-T therapy for multiple myeloma ciltacabtagene au

Scrip

Asia Deal Watch: Huadong Licenses Two Cancer ADCs From Heidelberg Pharma

 
• By Vibha Ravi, Anju Ghangurde, Joseph Haas, and Ian Haydock

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Huadong Pays $20m Up Front For ADCs Fro

Scrip

Asia Deal Watch: Otsuka Gets Japanese Rights To Perception’s Mood Disorder Candidate

 
• By Ian Haydock, Jung Won Shin, Vibha Ravi, and Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Otsuka Picks Up Perception’s R-Ketamine

Pink Sheet

AstraZeneca/MSD’s Koselugo Among 14 New Hopefuls At EMA

 
• By Neena Brizmohun

The European Medicines Agency has begun reviewing marketing applications for 14 new products including Koselugo (selumetinib), AstraZeneca and [MSD]’s newly US-approved treatment for pediatric patie